These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Circulatory function and hepatorenal syndrome in cirrhosis. Ruiz-del-Arbol L; Monescillo A; Arocena C; Valer P; Ginès P; Moreira V; Milicua JM; Jiménez W; Arroyo V Hepatology; 2005 Aug; 42(2):439-47. PubMed ID: 15977202 [TBL] [Abstract][Full Text] [Related]
14. Adaptations in control of blood flow with training: splanchnic and renal blood flows. McAllister RM Med Sci Sports Exerc; 1998 Mar; 30(3):375-81. PubMed ID: 9526882 [TBL] [Abstract][Full Text] [Related]
16. ET-3 is extracted by and induces potent vasoconstriction in human splanchnic and renal vasculatures. Weitzberg E; Hemsén A; Lundberg JM; Ahlborg G J Appl Physiol (1985); 1995 Oct; 79(4):1255-9. PubMed ID: 8567570 [TBL] [Abstract][Full Text] [Related]
17. The liver and the kidney: mutual clearance or mixed intoxication. Arroyo V Contrib Nephrol; 2007; 156():17-23. PubMed ID: 17464111 [TBL] [Abstract][Full Text] [Related]
18. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men. Böhm F; Pernow J; Lindström J; Ahlborg G Clin Sci (Lond); 2003 Feb; 104(2):143-51. PubMed ID: 12546636 [TBL] [Abstract][Full Text] [Related]
19. Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Cárdenas A Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508 [TBL] [Abstract][Full Text] [Related]
20. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention? Møller S; Henriksen JH Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]